INTRAVENOUS IMMUNOGLOBULIN: ANOTHER THERAPEUTIC APPLICATION
Inmunoglobulina intravenosa: Una nueva aplicación terapéutica
R. de Gracia, Dr. C. Jiménez, Dr. F. Gil, Dr. F. Escuin, Dr. J. Castell*, Dr. A. Sanz
Read
4154
Timeswas read the article
559
Total PDF
3595
Total HTML
Article information
ISSN: 20132514Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 0 | 6 |
| 2025 5 | 59 | 0 | 59 |
| 2025 4 | 43 | 0 | 43 |
| 2025 3 | 67 | 0 | 67 |
| 2025 2 | 42 | 0 | 42 |
| 2025 1 | 34 | 0 | 34 |
| 2024 12 | 31 | 0 | 31 |
| 2024 11 | 33 | 0 | 33 |
| 2024 10 | 40 | 0 | 40 |
| 2024 9 | 43 | 0 | 43 |
| 2024 8 | 51 | 0 | 51 |
| 2024 7 | 42 | 0 | 42 |
| 2024 6 | 39 | 0 | 39 |
| 2024 5 | 34 | 0 | 34 |
| 2024 4 | 35 | 0 | 35 |
| 2024 3 | 30 | 2 | 32 |
| 2024 2 | 41 | 15 | 56 |
| 2024 1 | 37 | 10 | 47 |
| 2023 12 | 21 | 6 | 27 |
| 2023 11 | 33 | 8 | 41 |
| 2023 10 | 42 | 9 | 51 |
| 2023 9 | 43 | 7 | 50 |
| 2023 8 | 46 | 10 | 56 |
| 2023 7 | 58 | 10 | 68 |
| 2023 6 | 66 | 17 | 83 |
| 2023 5 | 28 | 14 | 42 |
| 2023 4 | 15 | 2 | 17 |
| 2023 3 | 17 | 3 | 20 |
| 2023 2 | 22 | 4 | 26 |
| 2023 1 | 18 | 2 | 20 |
| 2022 12 | 33 | 3 | 36 |
| 2022 11 | 22 | 2 | 24 |
| 2022 10 | 26 | 6 | 32 |
| 2022 9 | 31 | 2 | 33 |
| 2022 8 | 33 | 6 | 39 |
| 2022 7 | 17 | 4 | 21 |
| 2022 6 | 27 | 5 | 32 |
| 2022 5 | 15 | 2 | 17 |
| 2022 4 | 24 | 2 | 26 |
| 2022 3 | 31 | 2 | 33 |
| 2022 2 | 23 | 4 | 27 |
| 2022 1 | 17 | 1 | 18 |
| 2021 12 | 32 | 7 | 39 |
| 2021 11 | 17 | 3 | 20 |
| 2021 10 | 19 | 7 | 26 |
| 2021 9 | 27 | 1 | 28 |
| 2021 8 | 18 | 5 | 23 |
| 2021 7 | 29 | 4 | 33 |
| 2021 6 | 14 | 1 | 15 |
| 2021 5 | 20 | 2 | 22 |
| 2021 4 | 27 | 15 | 42 |
| 2021 3 | 19 | 7 | 26 |
| 2021 2 | 14 | 11 | 25 |
| 2021 1 | 26 | 4 | 30 |
| 2020 12 | 8 | 4 | 12 |
| 2020 11 | 22 | 8 | 30 |
| 2020 10 | 5 | 3 | 8 |
| 2020 9 | 11 | 5 | 16 |
| 2020 8 | 24 | 9 | 33 |
| 2020 7 | 20 | 3 | 23 |
| 2020 6 | 16 | 6 | 22 |
| 2020 5 | 26 | 3 | 29 |
| 2020 4 | 26 | 10 | 36 |
| 2020 3 | 20 | 9 | 29 |
| 2020 2 | 21 | 6 | 27 |
| 2020 1 | 23 | 6 | 29 |
| 2019 12 | 18 | 5 | 23 |
| 2019 11 | 15 | 9 | 24 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 13 | 7 | 20 |
| 2019 8 | 7 | 8 | 15 |
| 2019 7 | 11 | 9 | 20 |
| 2019 6 | 10 | 3 | 13 |
| 2019 5 | 13 | 2 | 15 |
| 2019 4 | 16 | 16 | 32 |
| 2019 3 | 10 | 4 | 14 |
| 2019 2 | 5 | 6 | 11 |
| 2019 1 | 6 | 7 | 13 |
| 2018 12 | 24 | 12 | 36 |
| 2018 11 | 19 | 9 | 28 |
| 2018 10 | 19 | 7 | 26 |
| 2018 9 | 14 | 9 | 23 |
| 2018 8 | 13 | 7 | 20 |
| 2018 7 | 17 | 7 | 24 |
| 2018 6 | 11 | 12 | 23 |
| 2018 5 | 19 | 9 | 28 |
| 2018 4 | 10 | 5 | 15 |
| 2018 3 | 8 | 7 | 15 |
| 2018 2 | 9 | 6 | 15 |
| 2018 1 | 10 | 4 | 14 |
| 2017 12 | 19 | 9 | 28 |
| 2017 11 | 11 | 6 | 17 |
| 2017 10 | 11 | 5 | 16 |
| 2017 9 | 11 | 12 | 23 |
| 2017 8 | 19 | 4 | 23 |
| 2017 7 | 13 | 9 | 22 |
| 2017 6 | 15 | 7 | 22 |
| 2017 5 | 12 | 2 | 14 |
| 2017 4 | 20 | 7 | 27 |
| 2017 3 | 10 | 3 | 13 |
| 2017 2 | 11 | 6 | 17 |
| 2017 1 | 11 | 2 | 13 |
| 2016 12 | 12 | 4 | 16 |
| 2016 11 | 17 | 8 | 25 |
| 2016 10 | 24 | 4 | 28 |
| 2016 9 | 49 | 4 | 53 |
| 2016 8 | 72 | 0 | 72 |
| 2016 7 | 87 | 0 | 87 |
| 2016 6 | 79 | 0 | 79 |
| 2016 5 | 81 | 0 | 81 |
| 2016 4 | 53 | 0 | 53 |
| 2016 3 | 65 | 0 | 65 |
| 2016 2 | 73 | 0 | 73 |
| 2016 1 | 72 | 0 | 72 |
| 2015 12 | 103 | 0 | 103 |
| 2015 11 | 100 | 0 | 100 |
| 2015 10 | 77 | 0 | 77 |
| 2015 9 | 60 | 0 | 60 |
| 2015 8 | 63 | 0 | 63 |
| 2015 7 | 61 | 0 | 61 |
| 2015 6 | 24 | 0 | 24 |
| 2015 5 | 55 | 0 | 55 |
| 2015 4 | 7 | 0 | 7 |
Show all
